SEARCH

SEARCH BY CITATION

References

  • Benjamin Chi H, Sinkala M, Stringer EM et al. (2007) Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine. AIDS 21, 957964.
  • Byakika-Tusiime J, Crane J, Oyugi JH et al. (2009) Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS and Behavior 13(Suppl. 1), 8291.
  • Ekouevi DK, Coffie PA, Chaix ML et al. (2010) Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Cote d'Ivoire. Journal of the International AIDS Society 13, 28.
  • Jourdain G, Ngo-Giang-Huong N, Le Coeur S et al. (2004) Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. New England Journal of Medicine 351, 229240.
  • Lifson AR, Krantz EM, Eberly LE et al. (2011) Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort. AIDS Research and Therapy 8, 2.
  • Lockman S, Shapiro RL, Smeaton LM et al. (2007) Response to antiretroviral therapy after a single, peripartum dose of nevirapine. New England Journal of Medicine 356, 135147.
  • MOH Uganda. (2003) National Antiretroviral Treatment and Care Guidelines for Adults and Children, 1st edn. MOH Uganda, Uganda.
  • MOH Uganda. (2008) Policy guidelines for prevention of Mother-to-Child Transmission of HIV; Revised Edition August 2006; Circular update New Guidelines on Use of ARV for Prevention of Mother to Child Transmission of HIV (PMTCT) in Uganda; December 22 2008. Republic of Uganda, Ministry of Health.
  • MOH Uganda. (2009) National Antiretroviral Treatment and Care Guidelines for Adults, Adolscents and Children, 3rd edn. MOH Uganda, Uganda.
  • Mugyenyi P, Walker AS, Hakim J et al. (2010) Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet 375, 123131.
  • Namukwaya Z, Mudiope P, Kekitiinwa A et al. (2011) The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009. Journal of Acquired Immune Deficiency Syndromes 56, 6975.
  • Rawizza HE, Chaplin B, Meloni ST et al. (2011) Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clinical Infectious Diseases 53, 12831290.
  • Toro PL, Rabkin M, Flam R et al. (2012) Training multidisciplinary teams to deliver high-quality HIV care to families in resource-limited settings: the MTCT-Plus initiative experience. Journal of the Association of Nurses in AIDS Care 23, 548554.
  • WHO (2009) Panel on Antiretroviral Guidelines for Adults and Adolescents:Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1 2009; pp. 1161. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed (January 3 2011).